YA II PN, Ltd. 13D and 13G filings for NLS Pharmaceutics AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-04 7:39 pm Sale |
2024-09-30 | 13G | NLS Pharmaceutics AG NLSP |
YA II PN, Ltd. | 0 0.000% |
-98,978 (Position Closed) |
Filing |
| 2024-02-12 4:37 pm Purchase |
2023-12-31 | 13G | NLS Pharmaceutics AG NLSP |
YA II PN, Ltd. | 98,978 9.990% |
22,803 (+29.93%) |
Filing |
| 2023-01-03 3:58 pm Purchase |
2022-12-31 | 13G | NLS Pharmaceutics AG NLSP |
YA II PN, Ltd. | 76,175 9.990% |
36,030 (+89.75%) |
Filing |
| 2022-01-11 4:52 pm Purchase |
2021-12-31 | 13G | NLS Pharmaceutics AG NLSP |
YA II PN, Ltd. | 40,146 9.990% |
6,660 (+19.89%) |
Filing |
| 2021-10-07 6:24 pm Purchase |
2021-10-07 | 13G | NLS Pharmaceutics AG NLSP |
YA II PN, Ltd. | 33,486 9.990% |
33,486 (New Position) |
Filing |